Hims & Hers Health
American direct-to-consumer telehealth company offering prescription treatments, wellness products, and licensed healthcare services.
Hims & Hers Health – Q4 & Full-Year 2024 Financial Results (Investor Relations)Hims & Hers Health, Inc. is a San Francisco-based telehealth company founded in November 2017 by Andrew Dudum, Jack Abraham, and Hilary Coles through the Atomic Labs venture studio. The company operates a direct-to-consumer subscription platform connecting users to licensed healthcare professionals, offering prescription and over-the-counter treatments across sexual health, hair care, skincare, mental health, hormone health, weight loss, and dermatology. It serves consumers primarily via its websites and mobile application across the United States, United Kingdom, Canada, Germany, Ireland, France, Spain, and other markets.
The company went public in January 2021 via a SPAC merger with Oaktree Acquisition Corp. at a $1.6 billion valuation and trades on the NYSE under the ticker HIMS. In full-year 2024, Hims & Hers reported $1.5 billion in revenue (up 69% year-over-year), net income of $126 million, and 2.2 million subscribers (up 45% year-over-year). For 2025, it has guided for $2.3–$2.4 billion in revenue.
As a high-growth telehealth platform scaling rapidly in prescription-based wellness categories, Hims & Hers operates at the intersection of digital health, pharmacy, and consumer subscription services — making innovations in areas such as personalized medicine, digital diagnostics, and health technology directly relevant to its core business model.